Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma | NobleBlocks

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Public

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

N

Shared by NobleBlocks on Apr 15, 2018 • 12:00 AM UTC

Authors:

A. Eggermont

,

C. Blank

,

M. Mandalà

Subject

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Apr 15, 2018 • 12:00 AM UTC

NobleID:w1/20260522/10AD1D60

DOI:10.1056/NEJMoa1802357

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast